Omniab Inc (OABI) returns
Omniab returns over 3 years
$1,000 invested in Omniab three years ago was worth $1,138 at the close on October 30, 2026, with dividends reinvested: an average return of 4.4% a year. The same $1,000 in the S&P 500 (SPY) became $1,885.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +3.0% | — | $1,030 | -0.9% |
| 3 months | +156.8% | — | $2,568 | +2.1% |
| Year to date | +176.2% | — | $2,762 | +11.7% |
| 1 year | +243.0% | — | $3,430 | +12.4% |
| 3 years | +13.8% | +4.4% | $1,138 | +88.5% |
Omniab return by calendar year
| Year | OABI | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +176.2% | +11.7% | +164.5% |
| 2025 | -47.7% | +17.7% | -65.5% |
| 2024 | -42.6% | +24.9% | -67.5% |
| 2023 | +71.4% | +26.2% | +45.2% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: OABI financials
No forecast, no recommendation. This page describes Omniab Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.